Mendoza R B, Cantwell M J, Kipps T J
Human Gene Therapy Program, University of California-San Diego, La Jolla 92093-0663, USA.
J Immunol. 1997 Dec 15;159(12):5777-81.
Interaction of CD40 with its ligand (CD154) can induce CD40-bearing APCs to express immune stimulatory accessory molecules that facilitate immune recognition. We evaluated whether a plasmid vector encoding CD154 (pCD40L) could influence the immune response to a transgene protein encoded by coinjected plasmid DNA. We found that coinjection of pCD40L in BALB/c mice enhanced the Ab response to beta-galactosidase induced by i.m. or intradermal injection of placZ, a plasmid DNA vector encoding beta-galactosidase. Furthermore, i.m. or intradermal coinjection of pCD40L with placZ enhanced the generation of CTL specific for P815 cells transfected with placZ. This study indicates that pCD40L can serve as a genetic adjuvant capable of augmenting humoral and cellular immune responses to Ags encoded by plasmid DNA expression vectors.
CD40与其配体(CD154)相互作用可诱导表达CD40的抗原呈递细胞(APC)表达免疫刺激辅助分子,从而促进免疫识别。我们评估了编码CD154的质粒载体(pCD40L)是否会影响对共注射质粒DNA所编码转基因蛋白的免疫反应。我们发现,在BALB/c小鼠中共同注射pCD40L可增强肌肉注射或皮内注射placZ(一种编码β-半乳糖苷酶的质粒DNA载体)所诱导的针对β-半乳糖苷酶的抗体反应。此外,pCD40L与placZ进行肌肉注射或皮内共同注射可增强对用placZ转染的P815细胞具有特异性的细胞毒性T淋巴细胞(CTL)的产生。本研究表明,pCD40L可作为一种遗传佐剂,能够增强对质粒DNA表达载体所编码抗原的体液免疫和细胞免疫反应。